Beranda › Gangguan Metabolik › Missouri
Uji klinis Gangguan Metabolik di Missouri
7 studi untuk Gangguan Metabolik mencari peserta di lokasi di Missouri.
Kota di Missouri
Teks studi resmi (Bahasa Inggris)
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- Washington University School of Medicine (in St. Louis), St Louis
Menerima pesertaFase 1/2
Hingga usia 20 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT00920972A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, St Louis
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, St Louis
- 89bio Clinical Study Site, St Louis
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06419374Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
- Washington University School of Medicine, St Louis
Menerima peserta
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT06689800Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
- Washington University School of Medicine, St Louis
Menerima pesertaFase 1/2
1 Day – 21 Years · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT03128996Alzheimer"s Imaging Biomarkers in Obesity
- Washington University School of Medicine, St Louis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 60 · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT05077579Rare and Atypical Diabetes Network
- Washington University in St. Louis, St Louis
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 14 Agu 2025 · NCT05544266Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.